Bartosz J Grzywacz

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 33 Similar Profiles
Natural Killer Cells Medicine & Life Sciences
Adoptive Immunotherapy Medicine & Life Sciences
KIR Receptors Chemical Compounds
Ligands Medicine & Life Sciences
Histocompatibility Testing Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Unrelated Donors Medicine & Life Sciences
Peripheral T-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2022

Research Output 2002 2019

T-Cell Prolymphocytic Leukemia
Mitogen Receptors
T-Lymphocyte Subsets
Natural Killer Cells
Flow Cytometry

Electrical and noise characteristics of fin-shaped GaN/AlGaN devices for high frequency operation

Sai, P., But, D. B., Dub, M., Sakowicz, M., Grzywacz, B., Prystawko, P., Cywinski, G., Knap, W. & Rumyantsev, S., Sep 2019, 49th European Solid-State Device Research Conference, ESSDERC 2019. Editions Frontieres, p. 90-93 4 p. 8901702. (European Solid-State Device Research Conference; vol. 2019-September).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Cooley, S., He, F., Bachanova, V., Vercellotti, G. M., DeFor, T. E., Curtsinger, J. M., Robertson, P., Grzywacz, B., Conlon, K. C., Waldmann, T. A., McKenna, D. H., Blazar, B. R., Weisdorf, D. J. & Miller, J. S., Jan 1 2019, In : Blood Advances. 3, 13, p. 1970-1980 11 p.

Research output: Contribution to journalArticle

Open Access
Cell- and Tissue-Based Therapy
Acute Myeloid Leukemia
Natural Killer Cells

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

Erbe, A. K., Wang, W., Carmichael, L., Hoefges, A., Grzywacz, B., Reville, P. K., Ranheim, E. A., Hank, J. A., Kim, K. M., Seo, S., Mendonca, E. A., Song, Y., Kenkre, V. P., Hong, F., Gascoyne, R. D., Paietta, E., Horning, S. J., Miller, J. S., Kahl, B. & Sondel, P. M., Mar 12 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 70.

Research output: Contribution to journalArticle

Open Access
KIR Receptors
Follicular Lymphoma
Natural Killer Cells

Human NK cell development: One road or many?

Cichocki, F., Grzywacz, B. & Miller, J. S., Jan 1 2019, In : Frontiers in immunology. 10, AUG, Article 2078.

Research output: Contribution to journalArticle

Open Access
Natural Killer Cells
Linear Models
KIR Receptors
Lymphoid Tissue